Associate Professor Miriam Levy

Associate Professor Miriam Levy

Conjoint Associate Professor
Medicine & Health
School of Clinical Medicine

Associate Professor Miriam Levy is a Gastroenterologist and Hepatologist, and Head of Department at Liverpool Hospital, now the largest teaching hospital in Sydney, Australia. Miriam is a conjoint Associate Professor at University of NSW and Western Sydney University, Member of the Clinical Trials Network for Australian Liver Association and NSW Representative, Australian Liver Association Chapter of Gastroenterology Society of Australia.

Her research has addressed clinical questions in viral hepatitis and liver disease and includes work presented in 60 peer reviewed publications; focus recently on Viral Hepatitis which has significant morbidity and mortality in the community around Liverpool hospital due to the extraordinarily high local prevalence. Innovations of care in patient education material including the popular YouTube video hit “Understanding Hepatitis B” has been received in Australia and overseas with successful evaluations underpinning efficacy. Research into management of hepatitis B in pregnancy to prevent transmission as well as to optimise care post-partum has contributed novel strategies and changed practice. Her interest in de-monopolising specialist knowledge to facilitate primary care of patients is ongoing with exploration of new models of care including “Project ECHO” a group video conferencing tool between specialist hubs and primary care practitioners. Examination of utility and efficacy of screening for hepatitis in the emergency department is her current focus. Liver cancer is emerging as a major health challenge for patients in our community and the clinical service at Liverpool is now a multidisciplinary centre of excellence and emerging as a busy clinical trial site for HCC. ”

Qualifications:
MBBS (UNSW), FRACP, PhD

Society Memberships & Professional Activities:
FRACP, Gastroenterological Society (GESA)

Specific Research Keywords:
Fibroscan, Hepatocellular cancer, Haemangioma, Hepatitis B & Hepatitis C, Mother to child transmission of infection

Phone
+61408110412
Location
Liverpool Hospital
  • Book Chapters | 2014
    Levy MT; Crawford DHG, 2014, 'Treatment of Chronic Hepatitis B Infection', in Matthews, G; Robotin M; Allard N (ed.), B Positive - All You Wanted To Know About Hepatitis B: A Guide For Primary Care Providers, edn. 2nd, Australasian Society for HIV Medicine (ASHM), Darlinghurst, NSW, pp. 71 - 84, http://www.ashm.org.au/resources/Pages/1976963310.aspx
    Book Chapters | 2014
    Levy MT; Giles M; Hardikar W, 2014, 'Managing hepatitis B virus infection in pregnancy and children.', in Allard N; Matthews G; Robotin M (ed.), B Positive - All You Wanted To Know About Hepatitis B: A Guide For Primary Care Providers, edn. 2nd, Australasian Society for HIV Medicine (ASHM), Darlinghurst, NSW, pp. 103 - 110, http://www.ashm.org.au/images/Publications/Monographs/B%20Positive/B_Positive_2014_WEB.pdf#page=73
  • Journal articles | 2024
    Alshiwanna B; Levy M; Girolamo JD; Bagatella M; Petrovski I; Porritt R; Thomas D; Bakridi S; Tran H; Gryllis S; Tiglao M; Haack R; Peralta K; Doan J; Lawrence J; Cracknell R; Maley M; Foo H; Jones N; Dore G; Prince D, 2024, 'WED-470 Screening emergency admissions at risk of chronic hepatitis 3 extension (SEARCH 3X)-universal is better than risk-based screening for viral hepatitis', Journal of Hepatology, 80, pp. S676 - S676, http://dx.doi.org/10.1016/s0168-8278(24)01936-6
    Journal articles | 2024
    Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Sinclair M; George J; Bollipo S; McGarity B; Sievert W; MacQuillan G; Tse E; Nicoll A; Wade A; Cheng W; Roberts SK, 2024, 'Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care', Journal of Gastroenterology and Hepatology (Australia), 39, pp. 568 - 575, http://dx.doi.org/10.1111/jgh.16440
    Journal articles | 2024
    Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Sinclair M; George J; Sievert W; MacQuillan G; Tse E; Nicoll A; Wade A; Cheng W; Roberts SK, 2024, 'Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)', Drug and Alcohol Review, 43, pp. 1559 - 1572, http://dx.doi.org/10.1111/dar.13914
    Journal articles | 2024
    Girolamo JD; Prince D; Alshiwanna B; Porritt R; Thomas D; Bakridi S; Tran H; Gryllis S; Tiglao M; Haack R; Peralta K; Bagatella M; Petrovski I; Doan J; Cracknell R; Lawrence J; Maley M; Foo H; Jones N; Dore G; Levy M, 2024, 'WED-422 Screening for viral hepatitis in the emergency department-the methodology to automate a feasible, acceptable and effective solution', Journal of Hepatology, 80, pp. S657 - S657, http://dx.doi.org/10.1016/s0168-8278(24)01891-9
    Journal articles | 2024
    Gofton C; Di Bartolomeo A; Boutros R; Zurynski YA; Stafford-Bell F; Caldwell K; McCaughan G; Zekry A; Strasser SI; Levy M; Sheehan C; Goodall S; Davis JM; Sheahan L; Liu K; Greenaway S; Davison S; Du Huynh T; Quadri Z; Agar M; George J, 2024, 'Implementing palliative care in hepatocellular carcinoma ambulatory clinics—study protocol for Accelerated translational research in PRImary liver CAncer (APRICA) randomised controlled palliative care trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08603-x
    Journal articles | 2024
    Hume SJ; Wong DK; Yuen MF; Jackson K; Bonanzinga S; Vogrin S; Hall SAL; Burns GS; Desmond PV; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden S; Visvanathan K; Holmes JA; Thompson AJ, 2024, 'High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy', Liver International, 44, pp. 2605 - 2614, http://dx.doi.org/10.1111/liv.16029
    Journal articles | 2024
    Waller KMJ; Prince DS; Lai EHY; Levy MT; Strasser SI; McCaughan GW; Teng MLP; Huang DQ; Liu K, 2024, 'The Liver Frailty Index predicts survival in systemic therapy for hepatocellular carcinoma: a multicentre prospective cohort study', ESMO Gastrointestinal Oncology, 3, pp. 100043 - 100043, http://dx.doi.org/10.1016/j.esmogo.2024.100043
    Journal articles | 2024
    Wigg A; Tibballs J; Woodman R; Stuart K; Le H; Roberts SK; Olynyk JK; Strasser SI; Wallace M; Martin J; Haworth A; Hardcastle N; Loo KF; Tang C; Lee YY; Chu J; De Abreu Lourenco R; Koukourou A; De Boo D; McLean K; Buck J; Sawhney R; Nicoll A; Dev A; Wood M; Braund A; Weltman M; Khor R; Levy M; Wang T; Potter M; Haridy J; Raj A; Duncan O; Zekry A; Collier N; O’Beirne J; Holliday C; Trada Y; Tronidjaja J; George J; Pryor D, 2024, 'A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)', BMC Cancer, 24, http://dx.doi.org/10.1186/s12885-024-12504-2
    Journal articles | 2024
    Yeoh YKJ; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2024, 'Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia', Internal Medicine Journal, 54, pp. 602 - 612, http://dx.doi.org/10.1111/imj.16252
    Journal articles | 2023
    Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson AJ; Levy M; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2023, 'Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort', Digestive Diseases and Sciences, 68, pp. 291 - 303, http://dx.doi.org/10.1007/s10620-022-07483-y
    Journal articles | 2023
    Foo H; Phan F; Bagatella M; Petrovski I; Nagendra V; Acharya P; Levy M; Prakoso E, 2023, 'Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19', European Journal of Clinical Microbiology and Infectious Diseases, 42, pp. 799 - 801, http://dx.doi.org/10.1007/s10096-023-04599-5
    Journal articles | 2023
    Guliyara MA; Ermerak G; Levy M; Koo JH; Bassan M, 2023, 'Frailty predicts mortality in patients with upper gastrointestinal bleed: a prospective cohort study', Journal of Gastroenterology and Hepatology (Australia), 38, pp. 1292 - 1298, http://dx.doi.org/10.1111/jgh.16188
    Journal articles | 2023
    Hall SAL; Burns GS; Mooney BJ; Millen R; Morris R; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden S; Locarnini SA; Thompson AJ; Visvanathan K, 2023, 'Hepatitis B Virus Flares after Nucleot(s)ide Analogue Cessation Are Associated with Activation of Toll-Like Receptor Signaling Pathways', Journal of Infectious Diseases, 227, pp. 123 - 132, http://dx.doi.org/10.1093/infdis/jiac375
    Journal articles | 2023
    Jacob R; Prince DS; Pipicella JL; Nguyen A; Bagatella M; Alvaro F; Maley M; Foo H; Middleton P; Kayes T; DiGirolamo J; Davison S; Levy MT, 2023, 'Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care', Liver International, 43, pp. 60 - 68, http://dx.doi.org/10.1111/liv.15414
    Journal articles | 2023
    Thilakanathan C; Kayes T; Di Girolamo J; Nguyen V; Glass A; Manandhar S; Lawler J; Meredith C; Maley M; Lloyd A; Levy MT, 2023, 'Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore', Liver International, 43, pp. 69 - 76, http://dx.doi.org/10.1111/liv.15372
    Journal articles | 2023
    Thompson AJ; Jackson K; Bonanzinga S; Hall SAL; Hume S; Burns GS; Sundararajan V; Ratnam D; Levy MT; Lubel J; Nicoll AJ; Strasser SI; Sievert W; Desmond PV; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden DS; Canchola JA; Torres J; Siew P; Lau J; Brot BL; Kuchta A; Visvanathan K, 2023, 'Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000188
    Journal articles | 2022
    Clark PJ; Valery PC; Ward J; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2022, 'Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up', BMC Gastroenterology, 22, http://dx.doi.org/10.1186/s12876-022-02416-5
    Journal articles | 2022
    Hall SAL; Burns GS; Anagnostou D; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll A; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden D; Locarnini SA; Visvanathan K; Thompson A, 2022, 'Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels', Alimentary Pharmacology and Therapeutics, 56, pp. 310 - 320, http://dx.doi.org/10.1111/apt.16968
    Journal articles | 2022
    Kayes T; Crane H; Symonds A; Dumond J; Cottrell M; Di Girolamo J; Manandhar S; Lim TH; Gane E; Kashuba A; Levy MT, 2022, 'Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection', Alimentary Pharmacology and Therapeutics, 56, pp. 510 - 518, http://dx.doi.org/10.1111/apt.17040
    Journal articles | 2022
    Levy MT; Kashuba A; Gane E, 2022, 'Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection—Authors' reply', Alimentary Pharmacology and Therapeutics, 56, pp. 548 - 549, http://dx.doi.org/10.1111/apt.17102
    Journal articles | 2022
    Maharaj AD; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo EL; Philip J; Strasser SI; Stuart K; Thompson A; Tibballs J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Fink M; Goodwin M; Karapetis CS; Levy MT; Muller K; O'Beirne J; Pryor D; Seow J; Shackel N; Tallis C; Butler N; Olynyk JK; Reed-Cox K; Zalcberg JR; Roberts SK, 2022, 'Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus', Hepatology Communications, 6, pp. 3260 - 3271, http://dx.doi.org/10.1002/hep4.2089
    Journal articles | 2022
    Patwala K; Prince DS; Celermajer Y; Alam W; Paul E; Strasser SI; McCaughan GW; Gow P; Sood S; Murphy E; Roberts S; Freeman E; Stratton E; Davison SA; Levy MT; Clark-Dickson MC; Nguyen V; Bell S; Nicoll A; Bloom A; Lee AU; Ryan M; Howell J; Valaydon Z; Mack A; Liu K; Dev A, 2022, 'Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study', Hepatology International, 16, pp. 1170 - 1178, http://dx.doi.org/10.1007/s12072-022-10398-5
    Journal articles | 2022
    Prince DS; Girolamo JD; Pipicella JL; Bagatella M; Kayes T; Alvaro F; Maley M; Foo H; Middleton PM; Levy MT, 2022, 'Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?', Canadian Journal of Gastroenterology and Hepatology, 2022, pp. 1 - 9, http://dx.doi.org/10.1155/2022/3449938
    Journal articles | 2022
    Prince DS; Schlaphoff G; Davison SA; Huo YR; Xiang H; Chan MV; Lee AU; Thailakanathan C; Jebeili H; Rogan C; Al-Omary A; Gupta S; Lockart I; Tiwari N; Clark-Dickson M; Hillhouse JW; Laube R; Chang J; Nguyen V; Danta M; Cheng R; Strasser SI; Zekry A; Levy MT; Chan C; Liu K, 2022, 'Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study', Journal of Gastroenterology and Hepatology (Australia), 37, pp. 2173 - 2181, http://dx.doi.org/10.1111/jgh.15986
    Journal articles | 2021
    Dore G; Levy M, 2021, 'Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics', Clinical Infectious Diseases, http://dx.doi.org/10.1093/cid/ciaa1318
    Journal articles | 2021
    Levy MT; Terrault NA, 2021, 'Caesarean section or non-breastfeeding for prevention of MTCT—beware of sending the wrong message', Journal of Viral Hepatitis, 28, pp. 575 - 576, http://dx.doi.org/10.1111/jvh.13455
    Journal articles | 2021
    Lockart I; Hajarizadeh B; Alavi M; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival', Journal of Viral Hepatitis, 28, pp. 710 - 718, http://dx.doi.org/10.1111/jvh.13475
    Journal articles | 2021
    Lockart I; Hajarizadeh B; Buckley N; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy', Journal of Gastroenterology and Hepatology (Australia), 36, pp. 3515 - 3523, http://dx.doi.org/10.1111/jgh.15687
    Journal articles | 2021
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DHG; Levy MT; Shackel N, 2021, 'Australian recommendations for the management of hepatocellular carcinoma: a consensus statement', Medical Journal of Australia, 214, pp. 475 - 483, http://dx.doi.org/10.5694/mja2.50885
    Journal articles | 2021
    O'Brien ER; Whelan MC; Lama T; Levy M, 2021, 'Public health unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia', Public Health Research and Practice, 31, http://dx.doi.org/10.17061/PHRP30342010
    Journal articles | 2021
    Papaluca T; Roberts SK; Strasser SI; Stuart KA; Farrell G; Macquillan G; Dore GJ; Wade AJ; George J; Hazeldine S; O'Beirne J; Wigg A; Fisher L; McGarity B; Sawhney R; Sinclair M; Thomas J; Valiozis I; Weltman M; Wilson M; Woodward A; Ahlenstiel G; Haque M; Levy M; Prewett E; Sievert W; Sood S; Tse E; Valaydon Z; Bowden S; Douglas M; New K; O'Keefe J; Hellard M; Doyle J; Stoove M; Thompson AJ, 2021, 'Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics', Clinical Infectious Diseases, 73, pp. E3288 - E3295, http://dx.doi.org/10.1093/cid/ciaa1318
    Journal articles | 2021
    Prince DS; Pipicella JL; Fraser M; Alvaro F; Maley M; Foo H; Middleton PMC; Davison SA; Dore GJ; McCaughan GW; Levy MT, 2021, 'Screening Emergency Admissions at Risk of Chronic Hepatitis C (SEARCH) to diagnose or ‘re-diagnose’ infections is effective in Australia', Journal of Viral Hepatitis, 28, pp. 121 - 128, http://dx.doi.org/10.1111/jvh.13393
    Journal articles | 2021
    Razavi H; Blach S; Razavi-Shearer D; Abaalkhail F; Abbas Z; Abdallah A; Abrao Ferreira P; Abu Raddad LJ; Adda D; Agarwal K; Aghemo A; Ahmed A; Al-Busafi SA; Al-hamoudi W; Al-Kaabi S; Al-Romaihi H; Aljarallah B; AlNaamani K; Alqahtani S; Alswat K; Altraif I; Asselah T; Bacon B; Bessone F; Bizri AR; Block T; Bonino F; Brandão-Mello CE; Brown K; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Calleja JL; Castro Batänjer E; Chan HLY; Chang H; Chen CJ; Christensen PB; Chuang WL; Cisneros L; Cohen C; Colombo M; Conway B; Cooper C; Craxi A; Crespo J; Croes E; Cryer D; Cupertino de Barros FP; Derbala M; Dillon J; Doss W; Dou X; Doyle J; Duberg AS; Dugan E; Dunn R; Dusheiko G; El Khayat H; El-Sayed MH; Eshraghian A; Esmat G; Esteban Mur R; Ezzat S; Falconer K; Fassio E; Ferrinho P; Flamm S; Flisiak R; Foster G; Fung J; García-Samaniego J; Gish RG; Gonçales F; Halota W; Hamoudi W; Hassany M; Hatzakis A; Hay S; Himatt S; Hoepelman IM; Hsu YC; Hui YT; Hunyady B; Jacobson I; Janjua N; Janssen H; Jarcuska P; Kabagambe K; Kanto T; Kao JH; Kaymakoglu S; Kershenobich D; Khamis F; Kim DJ; Kim DY; Kondili LA; Kottilil S; Kramvis A, 2021, 'The case for simplifying and using absolute targets for viral hepatitis elimination goals', Journal of Viral Hepatitis, 28, pp. 12 - 19, http://dx.doi.org/10.1111/jvh.13412
    Journal articles | 2021
    Terrault NA; Cheung KW; Levy MT; Jourdain G, 2021, 'Reply to ‘Evidence against in utero transmission of hepatitis B virus’', Nature Reviews Gastroenterology and Hepatology, 18, pp. 445 - 446, http://dx.doi.org/10.1038/s41575-021-00456-y
    Journal articles | 2021
    Terrault NA; Levy MT; Cheung KW; Jourdain G, 2021, 'Viral hepatitis and pregnancy', Nature Reviews Gastroenterology and Hepatology, 18, pp. 117 - 130, http://dx.doi.org/10.1038/s41575-020-00361-w
    Journal articles | 2020
    Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E, 2020, 'Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia', Hepatobiliary and Pancreatic Diseases International, 19, pp. 541 - 546, http://dx.doi.org/10.1016/j.hbpd.2020.06.013
    Journal articles | 2020
    Crane HG; Davison SA; Levy MT, 2020, 'Editorial: the emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C', Alimentary Pharmacology and Therapeutics, 51, pp. 168 - 169, http://dx.doi.org/10.1111/apt.15525
    Journal articles | 2020
    Hall S; Burns G; Levy M; Lubel J; Nicoll A; Matthews G; Desmond P; Sievert W; Bowden S; Locarnini S; Holmes J; Visvanathan K; Thompson A, 2020, 'A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interim analysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare', Journal of Hepatology, 73, pp. S69 - S70, http://dx.doi.org/10.1016/s0168-8278(20)30674-7
    Journal articles | 2019
    Mohsen W; Chan P; Whelan M; Glass A; Mouton M; Young E; Tran Q; Arora S; Davison S; Lama T; Cobrador C; Levy M, 2019, 'Hepatitis C treatment for difficult to access populations: can telementoring (as distinct from telemedicine) help?', Internal Medicine Journal, 49, pp. 351 - 357, http://dx.doi.org/10.1111/imj.14072
    Journal articles | 2019
    Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, 49, pp. 1314 - 1322, http://dx.doi.org/10.1111/apt.15248
    Journal articles | 2018
    Ermerak GG; Behary J; Tran G; Koo K; Levy MT; Bassan MS, 2018, 'Mo1198 - Frailty and Aims65 Score Predict Mortality in Hospitalized Patients with Gastrointestinal Bleeding: A Prospective Cohort Study', Gastroenterology, 154, http://dx.doi.org/10.1016/s0016-5085(18)32479-x
    Journal articles | 2018
    Levy MT; Mohsen W, 2018, 'Author reply', Internal Medicine Journal, 48, pp. 486, http://dx.doi.org/10.1111/imj.13747
    Journal articles | 2018
    Lockart I; Das A; Merrett N; Levy M, 2018, 'Migration route of Fasciola into the liver', JGH open, 3, pp. 89 - 90, http://dx.doi.org/10.1002/jgh3.12101
    Journal articles | 2018
    Nicoll A; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy MT; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser S; McCaughan G, 2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, 154, pp. S - 1213, http://dx.doi.org/10.1016/s0016-5085(18)34006-x
    Journal articles | 2018
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063
    Journal articles | 2018
    Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT, 2018, 'Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing', Liver International, 38, pp. 1212 - 1219, http://dx.doi.org/10.1111/liv.13736
    Journal articles | 2017
    Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168
    Journal articles | 2017
    Mohsen W; Levy MT, 2017, 'Hepatitis A to E: what's new?', Internal Medicine Journal, 47, pp. 380 - 389, http://dx.doi.org/10.1111/imj.13386
    Journal articles | 2017
    Wang XM; Holz LE; Chowdhury S; Cordoba SP; Evans KA; Gall MG; De Ribeiro AJV; Zheng YZ; Levy MT; Yu DMT; Yao TW; Polak N; Jolly CJ; Bertolino P; McCaughan GW; Gorrell MD, 2017, 'The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury', Immunology and Cell Biology, 95, pp. 443 - 453, http://dx.doi.org/10.1038/icb.2016.116
    Journal articles | 2016
    Najjar Z; Gupta L; Pritchard-Jones J; Strasser SI; Levy MT; Liaw ST; Cowie BC, 2016, 'A survey of Sydney general practitioners' management of patients with chronic hepatitis B', The Medical journal of Australia, 204, pp. 74.e1 - 74.e4, http://dx.doi.org/10.5694/mja15.00524
    Journal articles | 2016
    Visvanathan K; Dusheiko G; Giles M; Wong ML; Phung N; Walker S; Le S; Lim SG; Gane E; Ngu M; Hardikar W; Cowie B; Bowden S; Strasser S; Levy M; Sasaduesz J, 2016, 'Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: Position paper produced by Australian, UK and New Zealand key opinion leaders', Gut, 65, pp. 340 - 350, http://dx.doi.org/10.1136/gutjnl-2015-310317
    Journal articles | 2015
    Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2015, 'Corrigendum to "efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus" (J Hepatol (2014) 61:502-507)', Journal of Hepatology, 63, pp. 1054, http://dx.doi.org/10.1016/j.jhep.2015.07.017
    Journal articles | 2015
    Kemp W; Levy M; Weltman M; Lubel J, 2015, 'Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis', Journal of Gastroenterology and Hepatology (Australia), 30, pp. 453 - 462, http://dx.doi.org/10.1111/jgh.12865
    Journal articles | 2014
    Ayres A; Yuen L; Jackson KM; Manoharan S; Glass A; Maley M; Yoo W; Hong SP; Kim SO; Luciani F; Bowden DS; Bayliss J; Levy MT; Locarnini SA, 2014, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', Journal of Viral Hepatitis, 21, pp. 809 - 817, http://dx.doi.org/10.1111/jvh.12212
    Journal articles | 2014
    Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2014, 'Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus', Journal of Hepatology, 61, pp. 502 - 507, http://dx.doi.org/10.1016/j.jhep.2014.04.038
    Journal articles | 2014
    Holt SG; Gracey DM; Levy MT; Mudge DW; Irish AB; Walker RG; Baer R; Sevastos J; Abbas R; Boyd MA, 2014, 'A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection', AIDS Research and Therapy, 11, http://dx.doi.org/10.1186/1742-6405-11-35
    Journal articles | 2014
    Nguyen V; Levy MT, 2014, 'Editorial: anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post-partum flare; authors' reply', Alimentary Pharmacology & Therapeutics, 40, pp. 116 - 116, http://dx.doi.org/10.1111/apt.12806
    Journal articles | 2014
    Nguyen V; Tan PK; Greenup AJ; Glass A; Davison S; Samarasinghe D; Holdaway S; Strasser SI; Chatterjee U; Jackson K; Locarnini SA; Levy MT, 2014, 'Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum flare', Alimentary Pharmacology and Therapeutics, 39, pp. 1225 - 1234, http://dx.doi.org/10.1111/apt.12726
    Journal articles | 2014
    Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; Mccaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J; Angus P; Chu G; Cornwall M; Douglas M; Hallinan R; Haque M; Hawkin G; Jackson H; Johnson R; Kronborg I; Lee A; Leggett B; Mire ML; Levy M; Lubel J; MacQuillan G; Masson J; McDonald J; McGarity B; Mollison L; Nicoll A; Ombiga J; Riordan S; Strasser S; Thompson A; Watson J; Wenman J; Wigg A; Zekry A, 2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424
    Journal articles | 2012
    Greenup A-J; Chatterjee U; Smith LE; Levy M, 2012, 'The hepatitis B bear: novel patient orientated information enhances patient understanding of the phases of hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27, pp. 166 - 166, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Levy MT, 2012, 'Preventing Perinatal Transmission of HBV: An Australian Perspective', Current Hepatitis Reports, 11, pp. 206 - 212, http://dx.doi.org/10.1007/s11901-012-0144-4
    Journal articles | 2012
    Tan PK; Chatterjee U; Glass A; Maley MW; Ayres A; Locarnini S; Levy M, 2012, 'Lamivudine in pregnancy: impact on hepatitis flares and HBeAg seroconversion post partum', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27, pp. 181 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600367&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Lawler J; Glass A; Chatterjee U; Wiseman E; Davison S; Manoharan S; Smith L; Yeo A; Ayres A; Locarnini S; Levy MT, 2011, 'Nucleot(s)ide analogues to prevent perinatal transmission of HBV: Lamivudine is effective but Tenofovir may be better', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, pp. 100 - 100, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Levy M; Glass A; Manoharan S; Paven G; Ng W; Wiseman E; Locarnini S; Ayres A, 2011, 'ANTIVIRAL-THERAPY IN PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: SEVERE POST PARTUM HEPATIC FLARES ARE COMMON AND USUALLY SELF LIMITING', JOURNAL OF HEPATOLOGY, 54, pp. S294 - S295, http://dx.doi.org/10.1016/S0168-8278(11)60735-6
    Journal articles | 2010
    Nguyen T; Thompson AJV; Bowden S; Croagh C; Bell S; Desmond PV; Levy M; Locarnini SA, 2010, 'Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia', Journal of Hepatology, 52, pp. 508 - 513, http://dx.doi.org/10.1016/j.jhep.2010.01.007
    Journal articles | 2010
    Robotin MC; Kansil MQ; George J; Howard K; Tipper S; Levy M; Phung N; Penman AG, 2010, 'Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: Effects on health services utilisation', BMC Health Services Research, 10, http://dx.doi.org/10.1186/1472-6963-10-215
    Journal articles | 2010
    Scott D; Wong J; Spicer ST; Dent H; Mensah FK; McDonald S; Levy MT, 2010, 'Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand', Transplantation, 90, pp. 1165 - 1171, http://dx.doi.org/10.1097/TP.0b013e3181f92548
    Journal articles | 2010
    Scott DR; Levy MT, 2010, 'Liver transient elastography (Fibroscan®): A place in the management algorithms of chronic viral hepatitis', Antiviral Therapy, 15, pp. 1 - 11, http://dx.doi.org/10.3851/IMP1474
    Journal articles | 2009
    Coupland H; Day C; Levy M; Maher L, 2009, 'Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users', Health Promotion Journal of Australia, 20, pp. 234 - 240
    Journal articles | 2009
    Levy MT; Wiseman E, 2009, 'In reply', Medical Journal of Australia, 191, pp. 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x
    Journal articles | 2009
    Levy MT; Wiseman E, 2009, 'Perinatal transmission of hepatitis B virus: an Australian experience REPLY', MEDICAL JOURNAL OF AUSTRALIA, 191, pp. 357 - 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x
    Journal articles | 2009
    Nguyen T; Thompson AJ; Desmond PV; Bowden S; Levy MT; Locarnini S, 2009, 'Serum HBeAg and HBsAg titres: changing levels during the natural history of chronic hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A299 - A299, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2009
    Robotin M; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy MT; Penman A, 2009, 'Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer', Journal of Hepatology, 50, pp. 990 - 998, http://dx.doi.org/10.1016/j.jhep.2008.12.022
    Journal articles | 2009
    Wiseman E; Fraser M; Holden S; Glass A; Kidson B; Heron LG; Maley M; Ayres A; Locarnini S; Levy MT, 2009, 'Perinatal transmission of hepatitis B virus: an Australian experience', Medical Journal of Australia, 190, pp. 489 - 492
    Journal articles | 2008
    Scott DR; Wong JKW; Spicer ST; Dent H; Levy MT, 2008, 'Hepatitis C has a significant impact after renal transplantation: analysis of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, pp. A260 - A260, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2007
    Gellert L; Jalaludin BB; Levy MT, 2007, 'Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most', Internal Medicine Journal, 37, pp. 516 - 522
    Journal articles | 2002
    Sohara N; Znoyko I; Levy MT; Trojanowska M; Reuben A, 2002, 'Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate', Journal of Hepatology, 37, pp. 214 - 221, http://dx.doi.org/10.1016/S0168-8278(02)00103-4
    Journal articles | 2000
    Levy MT; Trojanowska M; Reuben A, 2000, 'Oncostatin M: A cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells', Journal of Hepatology, 32, pp. 218 - 226, http://dx.doi.org/10.1016/S0168-8278(00)80066-5
    Journal articles | 2000
    McCaughan GW; Gorrell MD; Bishop GA; Abbott CA; Shackel NA; McGuinness PH; Levy MT; Sharland AF; Bowen DG; Yu D; Slaitini L; Church WB; Napoli J, 2000, 'Molecular pathogenesis of liver disease: An approach to hepatic inflammation, cirrhosis and liver transplant tolerance', Immunological Reviews, 174, pp. 172 - 191, http://dx.doi.org/10.1034/j.1600-0528.2002.017420.x
    Journal articles | 1999
    Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD, 1999, 'Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain', European Journal of Biochemistry, 266, pp. 798 - 810, http://dx.doi.org/10.1046/j.1432-1327.1999.00902.x
    Journal articles | 1999
    Havas T; Huang S; Levy M; Abi-Hanna D; Truskeyy P; Priestley J; Cox J; Wilson J, 1999, 'Posterior pharyngolaryngitis. Double-blind randomised placebo-controlled trial of proton pump inhibitor therapy', Australian Journal of Otolaryngology, 3, pp. 243 - 246
    Journal articles | 1999
    Havas T; Huang S; Levy MT; Abi-Hanna D; Truskett PG; Priestly J; Cox J; Wilson JS, 1999, 'Posterior pharyngolaryngitis: Double-blind placebo controlled trial of proton pump inhibitor therapy', Australian Journal of Otolaryngology, 3, pp. 243 - 246
    Journal articles | 1999
    Levy MT; McCaughan GW; Abbott CA; Park JE; Cunningham AM; Muller E; Rettig WJ; Gorrell MD, 1999, 'Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis', Hepatology, 29, pp. 1768 - 1778, http://dx.doi.org/10.1002/hep.510290631
    Journal articles | 1997
    Abbott CA; Gorrell MD; Levy MT; McCaughan GW, 1997, 'Molecular analyses of human and rat dipeptidyl peptidase IV', Advances in Experimental Medicine and Biology, 421, pp. 161 - 169, http://dx.doi.org/10.1007/978-1-4757-9613-1_21
    Journal articles | 1997
    Levy MT; Chen JJ; McGuinness PH; Koorey D; Sheil AGR; McCaughan GW, 1997, 'Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: Referral patterns and transplant outcomes', Journal of Gastroenterology and Hepatology (Australia), 12, pp. 453 - 459, http://dx.doi.org/10.1111/j.1440-1746.1997.tb00466.x
    Journal articles | 1996
    Levy MT; Torzillo P; Bookallil M; Sheil AGR; Mccaughan GW, 1996, 'Case Report: Delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis', Journal of Gastroenterology and Hepatology (Australia), 11, pp. 734 - 737, http://dx.doi.org/10.1111/j.1440-1746.1996.tb00323.x
    Journal articles | 1993
    Schmilovitz-Weiss H; Levy M; Thompson N; Dusheiko G, 1993, 'Viral markers in the treatment of hepatitis B and C', Gut, 34, http://dx.doi.org/10.1136/gut.34.2_Suppl.S26
  • Preprints | 2023
    Joseph Yeoh YK; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2023, Temporal change in etiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients with hepatocellular carcinoma in New South Wales, Australia, http://dx.doi.org/10.1101/2023.02.20.23286164
    Preprints | 2022
    Patwala K; Prince DS; Celermajer Y; Alam W; Paul E; Strasser SI; McCaughan GW; Gow P; Sood S; Murphy E; Roberts S; Freeman E; Stratton E; Davison SA; Levy MT; Clark-Dickson M; Nguyen V; Bell S; Nicoll A; Bloom A; Lee AU; Ryan M; Howell J; Valaydon Z; Mack A; Liu K; Dev A, 2022, Lenvatinib for the treatment of hepatocellular carcinoma - a real-world multicentre Australian cohort study, http://dx.doi.org/10.21203/rs.3.rs-1714922/v1
    Conference Posters | 2022
    Prince DS; Girolamo JD; Pipicella JL; Bagatella M; Kayes T; Alvaro F; Maley M; Foo H; Middleton PM; Levy MT, 2022, 'Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?', Vol. 2022, http://dx.doi.org/10.1155/2022/3449938
    Conference Abstracts | 2020
    Lockart I; Hajarizadeh B; Alavi M; Davison S; Section EP; Levy MT; George J; Dore GJ; Danta M, 2020, 'Sustained virological response before hepatitis C-related hepatocellular carcinoma diagnosis is associated with improved survival', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 53 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Ermerak GG; Behary J; Koo JH; Levy MT; Abi-Hanna D; Edwards PD; Bassan MS, 2019, 'OVER THE SCOPE CLIPS FOR PRIMARY THERAPY OF BLEEDING UPPER GASTROINTESTINAL ULCERS: A RETROSPECTIVE CASE CONTROL STUDY', in GASTROINTESTINAL ENDOSCOPY, MOSBY-ELSEVIER, CA, San Diego, Vol. 89, pp. AB488 - AB489, presented at Digestive Disease Week (DDW), CA, San Diego, 18 May 2019 - 21 May 2019, http://dx.doi.org/10.1016/j.gie.2019.03.798
    Conference Papers | 2019
    Jacob R; Levy M; Shackel N; Prakoso E; Joseph R; Tang S; Davison S, 2019, 'Stereotactic body radiation therapy for portal vein tumor thrombus is a safe and valuable therapy for the palliation of advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Tu T; Zehnder B; Levy M; Micali G; Tran L; Dabere O; Main N; Shackel N; Urban S, 2019, 'Hepatitis B virus (HBV) DNA integration is not driven by viral proteins', in Zeitschrift für Gastroenterologie, Georg Thieme Verlag KG, presented at 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber, 22 February 2019 - 23 February 2019, http://dx.doi.org/10.1055/s-0038-1677293
    Conference Papers | 2019
    Willmann L; Xie S; Levy M; Shackel N; Davison S; Fraser M; Stratton E; Prakoso E, 2019, 'Evaluating outpatient elective paracentesis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Ermerak GG; Behary J; Tran G; Koo K; Levy MT; Bassan MS, 2018, 'FRAILTY AND AIMS65 SCORE PREDICT MORTALITY IN HOSPITALIZED PATIENTS WITH GASTROINTESTINAL BLEEDING: A PROSPECTIVE COHORT STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, Vol. 154, pp. S703 - S704, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011102599&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Chan PP; Mohsen W; Whelan MC; Glass AL; Ladera A; Mouton M; Yeung E; Quyen T; Arora S; Davison S; Levy M, 2017, 'Project ECHO in Australia: A novel tele-mentoring service to aid Hepatitis C treatment in difficult to access populations', in HEPATOLOGY, WILEY, DC, Washington, pp. 317A - 318A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089800581&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Chan PPY; Mohsen W; Whelan M; Glass A; Ladera A; Mouton M; Yeung E; Tran Q; Arora S; Davison S; Levy MT, 2017, 'Project ECHO: A novel tele-mentoring service to aid hepatitis C treatment in difficult-to-access populations', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Clark PJ; Strasser SI; Leggett B; Angus PW; Zekry A; Levy M; Rong J; Tse E; McGarity B; Harding D; Nicoll A; Cheng W; Sievert W; Valery PC; Thompson AJ; Roberts SK, 2017, 'An Observational, Prospective Epidemiological Registry in Australia of HCV Liver Disease (OPERA-C)', in HEPATOLOGY, WILEY, DC, Washington, pp. 528A - 528A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089801129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Navani V; Chan P; Borchard J; Ladera A; Coppock J; Turner I; Shackel N; Levy M; Davison S; Prakoso E, 2017, 'Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Thilakanathan C; Wark G; Maley M; Davison S; Lee A; Glass AL; Shackel NA; Nguyen V; Jackson K; Lawler J; Locarnini S; Levy M, 2017, 'Can Quantitative HBsAg Threshold Predict High Viral Load and Risk of Mother to Child Transmission? Like Life, You Get What You Pay For', in HEPATOLOGY, WILEY, DC, Washington, pp. 1009A - 1010A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089802260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Thilakanathan C; Wark G; Maley MW; Davison S; Lee A; Glass A; Shackel N; Nguyen V; Jackson KM; Lawler J; Locarnini SA; Levy MT, 2017, 'Can quantitative HBsAg threshold predict high viral load and risk of mother-to-child transmission? Like life, you get what you pay for', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Wark G; Davison S; Glass A; Somes K; Levy MT, 2016, 'PERINATAL TRANSMISSION HBV IN AWESTERN SETTING; WHAT IS THE MATERNAL VIRAL THRESHOLD AT WHICH ANTIVIRAL THERAPY SHOULD BE CONSIDERED?', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, Vol. 64, pp. S360 - S360, presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)00532-8
    Conference Papers | 2015
    Davison SA; Roy S; Manassa D; Ermerak G; Borok N; Schlaphoff G; Levy MT, 2015, 'Survival benefits of multi-disciplinary team care in hepatocellular carcinoma at Liverpool Hospital, New South Wales, 2003–2013', in Journal of Gastroenterology and Hepatology, WILEY-BLACKWELL, pp. 95 - 116, http://dx.doi.org/10.1111/jgh.13093
    Conference Presentations | 2015
    Greenup A-J; Tan PK; Vi N; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2015, 'Efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus (vol 61, pg 502, 2014)', Vol. 63, pp. 1054 - 1054, http://dx.doi.org/10.1016/j.jhep.2015.07.017
    Conference Papers | 2015
    Jackson K; Yuen L; Nguyen V; Bayliss J; Locarnini S; Levy M, 2015, 'EFFECT OF TENOFOVIR ON KEY HEPATITIS B VIRUS MARKERS IN PREGNANT WOMEN DURING THE THIRD TRIMESTER AND POSTPARTUM', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S565 - S565, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)30857-6
    Conference Papers | 2014
    Dev AT; Mitchell J; Polkinghorne K; Skoien R; Stuart K; Cheng W; Lee A; Levy MT; Lubel J; Nazareth S; Wigg AJ; Warner SL; Roberts SK, 2014, 'Treatment safety and efficacy of Boceprevir-based triple therapy in genotype 1 hepatitis C: the Australian multi-centre Boceprevir real world experience (SABRE-C)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 674A - 674A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483803027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Gonsalkorala E; Nguyen V; Burns C; Glass AL; Levy MT, 2014, 'The landscape of pregant women with hepatitis B in a single centre', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1010A - 1010A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Gonsalkorala ES; Levy MT, 2014, 'The landscape of pregnant women with hepatitis B in a single center', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 77 - 77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Holt SG; Gracey DM; Mudge DW; Irish AB; Sevastos J; Walker RG; Baer RA; Levy MT; Boyd MA, 2014, 'RENAL FUNCTION TESTING IN PATIENTS ON TENOFOVIR ANTIVIRAL THERAPY', in NEPHROLOGY, WILEY-BLACKWELL, pp. 72 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Lord H; Treloar C; Cama E; Newland J; Levy MT, 2014, 'Understanding the phases of chronic hepatitis B: the problem and a novel solution using renamed phases, the hepatitis B bear and a video (see "Understanding Hepatitis B" on YouTube)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Lord HL; Newland J; Cama E; Treloar C; Levy MT, 2014, 'Understanding the Phases of Chronic Hepatitis B; the problem and a novel solution using renamed phases, the Hepatitis B Bear and a video (see " Understanding Hepatitis B " on YouTube)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1001A - 1002A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Nguyen V; Glass A; Jackson K; Greenup A; Davison S; Locarnini SA; Levy MT, 2014, 'UTILITY OF QUANTITATIVE HEPATITIS B E ANTIGEN AND SURFACE ANTIGEN IN THE PREDICTION OF HEPATITIS B E ANTIGEN SEROCONVERSION FOLLOWING PREGNANCY IN HBV', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, ENGLAND, London, pp. S295 - S295, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/S0168-8278(14)60840-0
    Conference Papers | 2014
    RAGHUNATH V; Levy MT; Koo K; Foo H; Borody TJ; Wong J, 2014, 'RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN A RENAL TRANSPLANT RECIPIENT SUCCESSFULLY TREATED WITH FECAL MICROBIOTA TRANSPLANTATION', in Nephrology, 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology,, Melbourne Convention and Exhibition Centre Melbourne, Australia, presented at 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology,, Melbourne Convention and Exhibition Centre Melbourne, Australia, 25 August 2014 - 27 August 2014, http://dx.doi.org/10.1111/nep.12303
    Conference Papers | 2013
    Ayres A; Yuen L; Jackson KM; Bowden DS; Bayliss J; Locarnini SA; Manoharan S; Glass A; Maley M; Levy MT; Yoo W; Hong SP; Kim S-O; Luciani F, 2013, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', in Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.12212
    Conference Papers | 2013
    Greenup A-J; Tan PK; Vi N; Glass AL; Lord HL; Chatterjee U; Davison S; Smith LE; Holdaway S; Samarasinghe D; Locarnini S; Levy M, 2013, 'Efficacy and safety of tenofovir in pregnancy to prevent Mother to Baby transmission of HBV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 625A - 625A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330252203048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Nguyen VI; Tan PK; Greenup A; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Locarnini SA; Levy MT, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Vi N; Tan PK; Greenup A-J; Glass AL; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Locarnini S; Levy M, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 641A - 642A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330252203080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Greenup A-J; Chatterjee U; Smith LE; Levy M, 2012, 'The Hepatitis B Bear: Novel patient orientated information enhances patient understanding of the phases of Hepatitis B', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 355A - 355A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 09 November 2012 - 13 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601333&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Tan PK; Chatterjee U; Glass AL; Maley M; Ayres A; Locarnini S; Levy M, 2012, 'Lamivudine in pregnancy: Impact on Hepatitis B flares and HBeAg seroconversion post partum', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 355A - 355A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 09 November 2012 - 13 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601334&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Ayres A; Yuen L; Manoharan S; Glass A; Nguyen R; Ng W; Maley M; Paven G; Levy MT; Locarnini S, 2011, 'LAMIVUDINE IN LATE PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: EFFECTIVENESS AND DETECTION OF ANTIVIRAL RESISTANCE', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S295 - S296, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60738-1
    Conference Papers | 2011
    Ayres A; Yuen L; Manoharan S; Glass AL; Maley M; Levy M; Jackson K; Locarnini SA, 2011, 'ULTRA DEEP PYROSEQUENCING IDENTIFIES MULTIDRUG RESISTANT HBV IN PREGNANT WOMEN UNDERGOING LAMIVUDINE THERAPY', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1074A - 1075A, presented at 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 04 November 2011 - 08 November 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295578003726&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Lawler J; Glass AL; Chatterjee U; Wiseman E; Davison S; Manoharan S; Smith L; Yeo AE; Ayres A; Locarnini S; Levy M, 2011, 'NUCLEOT(S)IDE ANALOGUES TO PREVENT PERINATAL TRANSMISSION OF HBV: LAMIVUDINE IS EFFECTIVE BUT TENOFOVIR MAY BE BETTER', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 892A - 892A, presented at 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 04 November 2011 - 08 November 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295578003343&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2010
    Davison SA; Nguyen R; Connor S; Ng W; Dobbins TA; Maley M; Monaharan S; Levy MT, 2010, 'Vitamin D deficiency is common in patients with genotype 1 chronic hepatitis C and is associated with lower rate of SVR', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A132 - A132, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Guirgis M; Manoharan S; Kwok R; Scott DR; Lee AU; Connor SJ; Levy M, 2009, 'TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN CHRONIC HEPATITIS B INFECTION: REDUCE NUMBER OF BIOPSIES & SAVE MONEY', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 543A - 543A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456000499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2009
    Guirgis M; Manoharan S; Scott DR; Kwok R; Lee AU; Connor SJ; Levy MT, 2009, 'Transient elastography (Fibroscan) in chronic hepatitis B infection: reduce number of biopsies & save money', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 24, pp. A308 - A308, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Levy M; Ayesa SL; Porritt R; Maley M; Nguyen T; Shaw T; Tattersall SJ; Ayres A; Locarnini S, 2009, 'QUANTITATIVE HBEAG AND HBSAG: LEVELS CORRELATE WITH HEPATITIS B VIRAL LOAD AND QUASI SPECIES SUGGESTING A SINGLE CONTROL MECHANISM', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 984A - 984A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001473&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2008
    Holden S; Connor SJ; Quinn JE; Levy MT, 2008, 'Is there still a role for lamivudine? Baseline HBeAg status and viral load at 6 and 12 months predicts long-term effectiveness of lamivudine in CHB patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A186 - A186, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 2008
    Lloyd AR; Cameron BA; Elliott LN; Galbraith SA; Li H; Teutsch S; Dolan K; Levy MT; Haber PS; Rawlinson WD; Kaldor JM; Ffrench R, 2008, 'Correlates of HCV seronegative-immune status in high risk IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A356 - A356, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 2008
    Lloyd AR; Teutsch S; Scheuer N; Dolan K; McCredie L; Ffrench R; Levy MT; Haber PS; Rawlinson WD; Kaldor JM, 2008, 'Predictors of HCV incidence in IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A346 - A347, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 2008
    Robotin M; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy MT, 2008, 'Modeling population-based chronic hepatitis B screening and treatment to prevent cirrhosis and liver cancer among high risk populations in Australia', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A359, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 2008
    Scott DR; Wong JK; Spicer ST; Dent H; Levy MT, 2008, 'HEPATITIS C IN DIALYSIS AND RENAL TRANSPLANT PATIENTS - ANALYSIS OF THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY REVEALS SIGNIFICANT IMPACT OF HEPATITIS C INFECTION AFTER RENAL TRANSPLANTATION', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 1130A - 1130A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757402519&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2008
    Tattersall S; Holden S; Maley M; Porritt RJ; Locarnini S; Levy MT, 2008, 'VIROLOGICAL HETEROGENEITY IN HEPATITIS B POSITIVE WOMEN; QUANTITATIVE HBeAg ESTIMATION DISTINGUISHES THOSE WITH SUBPOPULATIONS OF BASAL CORE PROMOTER MUTATIONS', in Journal of Hepatology, Elsevier Science BV, Amsterdam, Netherlands, pp. 365 - 366, presented at Journal of Hepatology
    Conference Papers | 2008
    Wiseman E; Fraser MA; Holden S; Glass AL; Kidson B; Heron LG; Maley M; Ayres A; Locarnini S; Levy M, 2008, 'PERINATAL TRANSMISSION OF HEPATITIS B VIRUS: VIRAL LOAD AND HBEAG STATUS ARE SIGNIFICANT RISK FACTORS', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 676A - 676A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2003
    Gorrell MD; Wang XM; Levy MT; Kable E; Marinos G; Cox G; McCaughan GW, 2003, 'Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection', in Advances in Experimental Medicine and Biology, pp. 235 - 243
    Conference Papers | 2000
    Gorrell MD; Abbott CA; Kähne T; Levy MT; Bret Church W; McCaughan GW, 2000, 'Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV: Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity', in Advances in Experimental Medicine and Biology, pp. 89 - 95

I have been able to support the research over the years with a combination of Pharma sponsored investigator initiated Grants for specific projects, New South Wales  Ministry of Health and EC Australia support for the Emergency Department screening pilot SEARCH research. 

Research Interests:
The Viral Hepatitis Research Group has a number of key areas of active clinical research. My group has already published unique Australian data on the rates of mother to child transmission of hepatitis b infection and currently investigating the role of anti viral therapy to prevent transmission of hepatitis B in this setting. The natural history of women with Hepatitis B infection remains to be defined, as much of the international literature on natural history does not reflect the course of the disease in women, which tends to be less severe. We are researching clinical characteristics that can facilitate clinical outcome prediction . These might  serve to influence therapeutic decisions at an early phase and disease.

Patients with viral hepatitis and cirrhosis have significant risk of hepatocellular cancer which has a poor prognosis without treatment. There are many therapeutic modalities depending on the stage of liver disease and stage of tumour. I am interested in the management of advanced hepatocellular cancer with recent research emphasis on the analysis of unmet supportive care needs. 

More recently I have investigated the role of screening those and risk for viral hepatitis within an emergency department presentation in an automated fashion. The goal is to maximise the opportunity during and engagement with the health service. We have a number of Grants supporting pilots  designed to model and iteratively improve testing  algorithms in this setting. the research incorporates cost analysis work, patient on health care worker and acceptance of screening research and further pilots of the (screening emergency admissions at risk of chronic hepatitis) that is SEARCH 1, 2 and 3-extension program.

 

Broad Research Areas:
Gastrointestinal Diseases, Infectious Diseases, Health Promotion, Clinical Research